AI 创业公司融资日历

1819 家公司 1840 轮融资 306 家已接到招聘板 全部在招职位 →

💡 刚融资 = 正在扩招。 创业公司拿到钱第一件事就是扩团队——先到先得。看到心仪的公司刚融资,点"→ 在招岗位",趁招聘高峰投。

轮次 全部 Series ASeedSeries BSeries CSeries DPre-SeedGrowthSeries EDebtSeries FSeries G+RoundPrivate Equity
领域 全部 FinTechAI InfrastructureEnterprise SaaSDeveloper ToolsHealthcareHardware & RoboticsConsumerCybersecurityMarketing & AdTechData & AnalyticsPropTech & ConstructionInfrastructureClimate TechHR & Workforce
筛选 ✅ 只看正在招人的 ≥ $50M 2026 年 ✕ 清除全部

当前显示 40 轮 · 合计 $3.6B · 其中 7 家正在招人

2026 年 7月1 轮

Chai Discovery Series C $400M Biotech 累计 $625M
AI-based molecular interactions platform for drug discovery performing state-of-the-art structure prediction and antibody design

2026 年 6月3 轮

Cellares Series D $327M Biotech 累计 $682M
Cellares is an integrated development and manufacturing organization (IDMO) for cell therapies, using automation and industrial-scale manufacturing sy…
Collate Series B $95M Biotech 累计 $125M
AI document generation platform for life sciences that automates regulatory paperwork for diagnostic, medical device, and drug development companies. …
NewLimit Series C $435M Biotech 累计 $760M
NewLimit develops epigenetic reprogramming medicines to restore youthful cellular function and treat diseases with large unmet needs. Co-founded by Br…

2026 年 4月2 轮

Cresilon Debt $5M Biotech 累计 $148M
Cresilon develops hemostatic medical devices, including gel-based technologies that rapidly stop bleeding for human and animal care.
未接到招聘板 待核实
Sennos Series B $20M Biotech 累计 $50M
Sennos builds AI software for fluidics and fermentation operations, focusing on process monitoring, optimization, and bioprocess analytics.
未接到招聘板 待核实

2026 年 3月3 轮

Mantis Biotech Seed $7M Biotech
Mantis Biotech builds infrastructure powering human-in-computer models, combining LLMs with high-fidelity physics simulations to convert rare human be…
未接到招聘板 待核实
Science Series C $230M Biotech 累计 $490M
Science Corporation is a neural engineering company developing brain-computer interface (BCI) technology to restore and enhance human vision. The comp…
未接到招聘板 待核实
Astromech Seed $11M Biotech 累计 $41M
Astromech is an AI-and-biology startup recruiting across genomics, evolutionary modeling, synthetic data, and alignment research to decode and simulat…
未接到招聘板 待核实

2026 年 2月7 轮

Loyal Series C $100M Biotech 累计 $250M
Loyal is a clinical-stage veterinary medicine company developing longevity drugs to help dogs live longer, healthier lives. They are the first company…
未接到招聘板 待核实
Angitia Series D $130M Biotech 累计 $420M
Angitia is a biotechnology company developing novel therapies for endocrine and metabolic diseases, including rare disease programs.
未接到招聘板 待核实
Osmo Series B $70M Biotech 累计 $130M
Osmo uses AI-powered olfactory intelligence to digitize and generate custom scent formulas, building the world's first AI-powered fragrance house with…
Third Arc Bio Series A $52M Biotech 累计 $217M
Third Arc Bio is an immunology and inflammation-focused biotechnology company developing targeted immune therapeutics across oncology and inflammatory…
未接到招聘板 待核实
Expert Intelligence Seed $6M Biotech
Expert Intelligence builds an AI decision layer for laboratory workflows in pharma, materials, food, and environmental testing, emphasizing governed a…
未接到招聘板 待核实
Colossal Biosciences Series C $60M Biotech 累计 $615M
Colossal Biosciences is a genetic engineering and de-extinction company using CRISPR technology to restore extinct species like the woolly mammoth and…
Phylo Seed $14M Biotech
Phylo is an applied AI research laboratory developing Biomni Lab, an integrated workspace enabling scientists to plan, author, execute, and collaborat…

2026 年 1月3 轮

Breakthru Medicine Series A $60M Biotech
Breakthru Medicine is a biotech company developing novel oncology therapies, with a focus on first-in-class radioconjugate treatment approaches for ca…
未接到招聘板 待核实
Converge Bio Series A $25M Biotech 累计 $30M
Converge Bio develops generative AI platform trained on molecular data to help pharma and biotech companies discover and develop more effective drugs …
未接到招聘板 待核实
Prudentia Sciences Series A $20M Biotech 累计 $27M
Prudentia Sciences develops AI software for life-sciences diligence, asset valuation, and investment decision support across biopharma programs.
未接到招聘板 待核实

2025 年 12月3 轮

Edison Scientific Seed $70M Biotech
Edison Scientific builds and deploys autonomous AI scientist agents to accelerate research and drug development. Its flagship platform, Kosmos, runs h…
未接到招聘板 待核实
Medra Series A $52M Biotech 累计 $63M
Medra develops autonomous AI-powered robotic scientists that run and refine laboratory experiments end-to-end, interfacing with standard lab tools to …
未接到招聘板 待核实
Morphocell Technologies Series A $10M Biotech 累计 $50M
Regenerative medicine company developing stem cell-derived tissue and organ replacement therapies for liver disease using iPSC-derived platform techno…
未接到招聘板 待核实

2025 年 11月3 轮

Profluent Series B $106M Biotech 累计 $150M
AI-first protein design company using deep generative models to create novel, functional proteins for applications in biomedicine, agriculture, and ge…
未接到招聘板 待核实
Red Queen Bio Seed $15M Biotech
AI biosecurity company developing AI-powered defenses against biological threats and bioweapons. Spun out from mRNA therapeutics company Helix Nano, p…
未接到招聘板 待核实
Bindwell Seed $6M Biotech
Bindwell is an AI-powered pesticide discovery company that uses machine learning models 4x faster than DeepMind's AlphaFold to screen billions of mole…
未接到招聘板 待核实

2025 年 10月3 轮

Generation Lab Seed $11M Biotech 累计 $15M
Generation Lab is an AI biotechnology company building an agent scientist platform to program the immune system and accelerate antibody and cell thera…
未接到招聘板 待核实
Lila Sciences Series A $350M Biotech 累计 $550M
A platform using artificial intelligence to support research in life sciences, chemical sciences, and materials sciences through autonomous AI labs bu…
未接到招聘板 待核实
NILO Therapeutics Series A $101M Biotech
Nilo Therapeutics is a New York-based biotech developing a new class of medicines that harness brain-body neural circuits to restore immune homeostasi…
未接到招聘板 待核实

2025 年 9月2 轮

Until Series A $58M Biotech 累计 $106M
Until Labs develops reversible cryopreservation technology to pause biological time, starting with organ-scale preservation to extend the viability of…
未接到招聘板 待核实
Enveda Series D $150M Biotech 累计 $517M
AI-powered drug discovery platform advancing nature-inspired therapeutics from plants and natural products into clinical development.
未接到招聘板 待核实

2025 年 8月2 轮

Debut Series B $20M Biotech 累计 $85M
Debut is a beauty biotechnology company that uses AI-powered ingredient discovery and biofermentation to create high-performing, sustainable beauty in…
未接到招聘板 待核实
Convoke Seed $9M Biotech
AI-native operating system for biopharma companies, unifying internal and external data, codifying decision logic, and generating critical deliverable…
未接到招聘板 待核实

2025 年 5月1 轮

Biostate AI Series A $12M Biotech 累计 $20M
A scalable biological data collection service providing multi-omics data for research.
未接到招聘板 待核实

2025 年 2月1 轮

Latent Series A $40M Biotech 累计 $50M
AI foundation models platform focused on making biology programmable and accelerating protein design.
未接到招聘板 待核实

2024 年 12月1 轮

Manifold Bio Series B $33M Biotech 累计 $78M
The first high-throughput in vivo discovery engine combining massively multiplexed in vivo screening and AI-powered design to create tissue-targeted m…
未接到招聘板 待核实

2024 年 11月2 轮

Cradle Series B $73M Biotech 累计 $103M
Cradle builds an AI-powered protein engineering platform that helps biotech teams design and optimize proteins faster across discovery workflows.
未接到招聘板 待核实
Anthrogen Seed $4M Biotech 累计 $5M
A biotechnology company developing carbon-negative polymers and materials using genetically engineered enzymes.
未接到招聘板 待核实

2024 年 6月1 轮

Formation Bio Series D $372M Biotech 累计 $608M
Formation Bio (formerly TrialSpark) is an AI-native pharmaceutical company that acquires and develops clinical-stage drugs using a technology platform…
未接到招聘板 待核实

2022 年 1月1 轮

Guardian Bio Seed $500,000 Biotech
Guardian Bio is a biotech company developing dendritic cell-based therapies designed to restore anti-tumor immune responses in cancer patients.
未接到招聘板 待核实

2021 年 10月1 轮

Kingdom Supercultures Series A $25M Biotech 累计 $29M
Kingdom Supercultures engineers microbes to create functional ingredients for food and beverage brands.
未接到招聘板 待核实